3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
110
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
6
Neoplasms
4
Neoplasm Metastasis
3
Inflammatory Breast Neoplasms
3
Carcinoma, Ductal, Breast
3
Breast Neoplasms, Male
3
Infertility
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Cancer Female
2
Sleep Wake Disorders
1
Quality of Life
1
Pulmonary Fibrosis
1
Prostatic Neoplasms
1
Primary Breast Cancer
1
Polycystic Ovary Syndrome
1
Paget's Disease, Mammary
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Recurrence, Local
1
Liver Neoplasms
1
Hot Flashes
1
Fatigue
1
Cardiotoxicity
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Carcinoma, Hepatocellular
1
Breast Cancer Subjects
1
Interventions
ribociclib
1
Tamoxifen
1
Letrozole
1
Goserelin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Advanced Metastatic Breast Cancer
×
Tamoxifen
×
Clear all
NCT02278120
2024-03-12
MONALEESA-7
Novartis
Phase 3
Completed
672 enrolled
16 charts
1 FDA